Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Intellipharmaceutics: Fiscal Q4 Earnings Snapshot
By AP News - Jun 06, 2023, 10:30 AM ET
Last Updated - Jun 21, 2023, 12:26 PM EDT
TORONTO (AP) — TORONTO (AP) — Intellipharmaceutics International Inc. (IPCIF) on Tuesday reported a loss of $875,000 in its fiscal fourth quarter.
The Toronto-based company said it had a loss of 9 cents per share.
Sponsored
The extended-release drug developer posted revenue of $46,700 in the period. Its adjusted revenue was $47,000.
For the year, the company reported a loss of $2.9 million, or 9 cents per share. Revenue was reported as $657,000.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a IPCIF">Zacks stock report on IPCIF at https://www.zacks.com/ap/IPCIF
Sponsored
Read More from Investing
Popular News
Latest News
